In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Merck KGAA puts up offer to acquire Schering AG; withdrawn

Executive Summary

Merck KGAA has announced its intention to acquire Schering AG by way of an unsolicited €14.6bn ($17.4bn) bid. Schering initially rejected the €77-per-share offer, stating that it significantly undervalued the company (shares of Schering rose to over €84 apiece following the announcement), but Merck is standing strong, confident that another bidder will not top its asking price.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Withdrawn
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash

Related Companies